Masimo Corp. (MASI)

132.26
1.24 0.93
NASDAQ : Health Technology
Prev Close 133.50
Open 133.50
Day Low/High 131.29 / 133.55
52 Wk Low/High 81.56 / 135.75
Volume 418.18K
Avg Volume 412.90K
Exchange NASDAQ
Shares Outstanding 53.17M
Market Cap 7.08B
EPS 3.70
P/E Ratio 38.66
Div & Yield N.A. (N.A)

Latest News

Masimo To Present At Raymond James 40th Annual Institutional Investors Conference

Masimo To Present At Raymond James 40th Annual Institutional Investors Conference

Masimo (NASDAQ: MASI) today announced that its management is scheduled to present at the Raymond James 40th Annual Institutional Investors Conference at the J.

Masimo Reports Fourth Quarter And Full Year 2018 Financial Results

Masimo Reports Fourth Quarter And Full Year 2018 Financial Results

Masimo (Nasdaq: MASI) today announced its financial results for the fourth quarter and full year ended December 29, 2018.

Masimo Root® With SedLine® And O3® (Photo: Business Wire)

Masimo Root® With SedLine® And O3® (Photo: Business Wire)

Masimo (NASDAQ: MASI) announced today the findings of a series of four clinical cases, recently published in the Canadian Journal of Anesthesiology, in which researchers at the University of Montreal found that combined use of Masimo SedLine ® brain...

Masimo Rad-97™ With Eve™ (Photo: Business Wire)

Masimo Rad-97™ With Eve™ (Photo: Business Wire)

Recently at Arab Health 2019, the Saudi Arabia Ministry of Health (MOH) and Masimo (NASDAQ: MASI) jointly announced the implementation of an automation solution designed to streamline the process of critical congenital heart disease (CCHD) screening of...

Masimo Announces Doctella™, A Secure Cloud-based Patient Engagement And Remote Care Automation Platform

Masimo Announces Doctella™, A Secure Cloud-based Patient Engagement And Remote Care Automation Platform

Masimo (NASDAQ: MASI) announced today the launch of Doctella™, a home-based patient engagement and remote care automation platform.

Masimo MightySat™ Rx With RRp® (Photo: Business Wire)

Masimo MightySat™ Rx With RRp® (Photo: Business Wire)

Masimo (NASDAQ: MASI) announced today FDA clearance of the measurement of respiration rate from the pleth (RRp ®) on the MightySat™ Rx spot-check fingertip pulse oximeter, as well as its indication for use in the home environment.

Masimo Iris® Device Management System (Photo: Business Wire)

Masimo Iris® Device Management System (Photo: Business Wire)

Masimo (NASDAQ: MASI) announced today the U.S.

Masimo Announces Select Preliminary Full Year 2018 Financial Results And 2019 Outlook

Masimo Announces Select Preliminary Full Year 2018 Financial Results And 2019 Outlook

Masimo Corporation (NASDAQ: MASI) today announced select preliminary results for the full year December 29, 2018 and provided estimates for its full year 2019 financial guidance.

Julie A. Shimer Ph.D. Joins Masimo's Board Of Directors

Julie A. Shimer Ph.D. Joins Masimo's Board Of Directors

Masimo (NASDAQ: MASI), a global medical technology developer and manufacturer of innovative noninvasive patient monitoring technologies, announced today that Julie A.

Masimo To Present At 37th Annual J.P. Morgan Healthcare Conference

Masimo To Present At 37th Annual J.P. Morgan Healthcare Conference

Masimo (NASDAQ: MASI) today announced that its management is scheduled to present at the 37th Annual J.

Masimo Founder And CEO Joe Kiani Speaking At The 2018 IPO Education Foundation Awards Dinner (Photo: Business Wire)

Masimo Founder And CEO Joe Kiani Speaking At The 2018 IPO Education Foundation Awards Dinner (Photo: Business Wire)

Masimo (NASDAQ: MASI) Founder and CEO Joe Kiani was honored last night at the 2018 IPO Education Foundation Awards Dinner with the first ever IP Champion Award.

Technically Attractive Masimo Looks Ready for a Rally Back to the Highs

Technically Attractive Masimo Looks Ready for a Rally Back to the Highs

Traders could go long Masimo at current levels and on strength above $113.

This Market is Treacherous: Cramer's 'Mad Money' Recap (Thursday 12/11/18)

This Market is Treacherous: Cramer's 'Mad Money' Recap (Thursday 12/11/18)

Tuesday's wild market ride was all about China, Jim Cramer says.

Masimo Rad-67™ With SpHb® (Photo: Business Wire)

Masimo Rad-67™ With SpHb® (Photo: Business Wire)

Masimo (NASDAQ: MASI) announced today that a new consensus statement on postoperative anemia management was published in Anaesthesia by an international panel of clinicians specializing in patient blood management, which includes clear guidance on the use...

Masimo To Present At Stifel 2018 Healthcare Conference

Masimo To Present At Stifel 2018 Healthcare Conference

Masimo (NASDAQ: MASI) today announced that its management is scheduled to present at the Stifel 2018 Healthcare Conference at the Palace Hotel in New York on Wednesday, November 14, 2018 at 10:15 a.

Masimo Reports Third Quarter 2018 Financial Results

Masimo Reports Third Quarter 2018 Financial Results

Masimo (NASDAQ: MASI) today announced its financial results for the third quarter ended September 29, 2018.

Masimo Radical-7® With RD SET™ Sensor And SET® Pulse Oximetry (Photo: Business Wire)

Masimo Radical-7® With RD SET™ Sensor And SET® Pulse Oximetry (Photo: Business Wire)

Masimo (NASDAQ: MASI) announced today that RD SET™ sensors with Masimo Measure-through Motion and Low Perfusion™ SET ® pulse oximetry have received FDA clearance with improved SpO 2 accuracy specifications for all patients > 3 kg.

Masimo To Report Third Quarter 2018 Financial Results After Market Close On Wednesday, October 31

Masimo To Report Third Quarter 2018 Financial Results After Market Close On Wednesday, October 31

Masimo (NASDAQ: MASI) announced today that it will release third quarter 2018 financial results for the period ended September 29, 2018, after the market closes on Wednesday, October 31, 2018.

Masimo Patient SafetyNet™, Root®, Radius-7®, Radical-7®, And Replica™ (Photo: Business Wire)

Masimo Patient SafetyNet™, Root®, Radius-7®, Radical-7®, And Replica™ (Photo: Business Wire)

Masimo (NASDAQ: MASI) announced today that Bassett Medical Center, a 180-bed Cooperstown, New York hospital, has adopted Masimo Patient SafetyNet™ and Root ® with Vital Signs Check across its 54-bed medical-surgical unit, including pediatric beds.

Masimo Root® With Radical-7®, ORi™, And RD Rainbow SET™ Sensor (Photo: Business Wire)

Masimo Root® With Radical-7®, ORi™, And RD Rainbow SET™ Sensor (Photo: Business Wire)

Masimo (NASDAQ: MASI) announced today the findings of an abstract presented at the 2018 Congress of the French Society of Anesthesia and Resuscitation (SFAR) in Paris in which researchers at CHU Angers in France investigated the ability of Masimo ORi™...

Masimo To Present At Morgan Stanley 16th Annual Global Healthcare Conference

Masimo To Present At Morgan Stanley 16th Annual Global Healthcare Conference

Masimo (NASDAQ: MASI) today announced that its management is scheduled to present at the Morgan Stanley 16th Annual Global Healthcare Conference at the Grand Hyatt Hotel in New York on Thursday, September 13, 2018 at 1:30 p.

Masimo Root® With Radical-7®, RRa®, And The RAS-45 Infant/Neonatal Sensor (Photo: Business Wire)

Masimo Root® With Radical-7®, RRa®, And The RAS-45 Infant/Neonatal Sensor (Photo: Business Wire)

Masimo (NASDAQ: MASI) announced today FDA clearance of RAS-45, an acoustic respiration sensor for rainbow Acoustic Monitoring ® (RAM ®), for infant and neonatal patients.

Masimo Radical-7® With PVi® (Photo: Business Wire)

Masimo Radical-7® With PVi® (Photo: Business Wire)

Masimo (NASDAQ: MASI) announced today the findings of a study recently published in BMC Anesthesiology in which researchers at University Hospital Linköping, Sweden, compared the performance of goal-directed fluid therapy (GDFT) using invasive esophageal...

Masimo Root® With Radical-7® And ORi™ (Photo: Business Wire)

Masimo Root® With Radical-7® And ORi™ (Photo: Business Wire)

Masimo (NASDAQ: MASI) announced today the findings of a study recently published in Anesthesia & Analgesia in which researchers at the University of Groningen, the Netherlands, and Ghent University, Belgium, investigated the ability of Masimo ORi™ (Oxygen...

Masimo Radical-7® Pulse CO-Oximeter® (Photo: Business Wire)

Masimo Radical-7® Pulse CO-Oximeter® (Photo: Business Wire)

Masimo (NASDAQ: MASI) announced today the findings of a recently published study in which researchers investigated whether home pulse oximetry monitoring might be a useful initial screening method of determining which children with Down syndrome (DS) -...

H Michael Cohen Joins Masimo's Board Of Directors

H Michael Cohen Joins Masimo's Board Of Directors

Masimo (NASDAQ: MASI), a global medical technology developer and manufacturer of innovative noninvasive patient monitoring technologies, announced today that H Michael Cohen, former Vice Chairman of Healthcare Investment Banking at Deutsche Bank...

Masimo Reports Second Quarter 2018 Financial Results And Announces Board Authorization Of A New Stock Repurchase Program

Masimo Reports Second Quarter 2018 Financial Results And Announces Board Authorization Of A New Stock Repurchase Program

Masimo (NASDAQ: MASI) today announced its financial results for the second quarter ended June 30, 2018.

Masimo Radius-7® Pulse CO-Oximeter® (Photo: Business Wire)

Masimo Radius-7® Pulse CO-Oximeter® (Photo: Business Wire)

Masimo (NASDAQ: MASI) announced today the findings of a recently published study in which researchers at Dartmouth-Hitchcock Medical Center investigated the impact of an integrated clinical monitoring system, using various Masimo technologies and devices,...

TheStreet Quant Rating: A- (Buy)